mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis
International Immunopharmacology · 2024-06 · 134 · 112217
DOI: 10.1016/j.intimp.2024.112217 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Yue Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, People's Republic of China; Grad…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, TOR Serine-Threonine Kinases, Signal Transduction, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The imbalance between T helper cell 17 (Th17)and regulatory T cells (Treg) cells leading to inflammation has an important role in the pathogenesis of ulcerative colitis (UC). Mammalian target of rapamycin (mTOR) can regulate the differentiation of T cells, but the specific pathway leading mTOR to regulate Th17/Treg cells in UC remains unclear. Our aim with this study was to investigate the effects of mTOR overexpression and silencing on the hypoxia inducible factor-1α (HIF-1α) - Th17/Treg signaling pathway. To mimic a human study, we established a colon cancer epithelial cell line (HT-29) co-culture system with human CD4+ T cells, and we treated the cells with TNF-α. We observed the effects of mTOR on the HIF-Th17/Treg signaling pathway to determine whether mTOR is involved in the regulatory mechanism. Under the stimulation of TNF-α, the levels of HIF-1α in CD4+T cells were increased in the HT-29 co-culture with CD4+ T cells, promoting glycolysis, increasing the Th17 proportion, decreasing the Treg proportion, increasing the pro-inflammatory factors levels, and decreasing the anti-inflammatory factors levels. Moreover, after mTOR silencing, the HIF-1α level and cell glycolysis levels decreased, Th17 cell differentiation decreased, the pro-inflammatory factor levels decreased, and the anti-inflammatory factor levels increased. In contrast, mTOR overexpression lead to the opposite results.mTOR promotes inflammation by regulating the HIF signaling pathway during UC, and silencing mTOR may alleviate inflammation. An mTOR inhibitor is a potential therapeutic target for UC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, People's Republic of China; Graduate School of Anhui University of Chinese Medicine, Hefei 230031, Peo…
- Department of Rheumatology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, People's Republic of China.
- Department of Gastroenterology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, People's Republic of China. Electronic address: zhaansheng@ahtcm.edu.cn.
Zitieren
APA
Wang, Y., Li, M., & Zha, A. (2024). mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis. International Immunopharmacology, 134, 112217. https://doi.org/10.1016/j.intimp.2024.112217
Vancouver
Wang Y, Li M, Zha A. mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis. International Immunopharmacology. 2024;134:112217. doi:10.1016/j.intimp.2024.112217
BibTeX
@article{Wang2024,
author = {Wang, Yue and Li, Ming and Zha, AnSheng},
title = {mTOR promotes an inflammatory response through the HIF1 signaling pathway in ulcerative colitis},
journal = {International Immunopharmacology},
year = {2024},
volume = {134},
pages = {112217},
doi = {10.1016/j.intimp.2024.112217}
}
EUVIMED